Observational study of heparin/protamine effects during extracorporeal circulation

Observational study of heparin/protamine effects during extracorporeal circulation - Heparin/protamine effects on cardiac function

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044929

Enrollment

Registered

2021-07-21

Start date

2020-02-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular surgery patients receiving extracorporeal circulation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Provide signed, written informed consent. 2.Patient to perform an operation using heparin/protamine

Exclusion criteria

Exclusion criteria: cardiovascular surgery patients without extracorporeal circulation

Design outcomes

Primary

Measure	Time frame
Optimal dosis of Heparin-protamine during extracorporeal circulation	—

Secondary

Measure	Time frame
Factors affecting post-operative atrial fibrillation and other arrythmias	—

Countries

Japan

Contacts

Public ContactYasuharu Yamada

Suzuka University of Medical Science Department of Clinical Engineering, Faculty of Medical Engineering

yamada@suzuka-u.ac.jp059-383-8991

Outcome results